XML 19 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
Marketable Securities
9 Months Ended
Sep. 30, 2022
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities

3. Marketable Securities

The following table summarizes the Company’s available-for-sale marketable securities as of September 30, 2022 and December 31, 2021 at net book value:

 

 

September 30, 2022

 

 

 

Amortized
Cost

 

 

Gross Unrealized
Gains

 

 

Gross Unrealized
Losses

 

 

Estimated Fair
Value

 

 

 

(In thousands)

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury and other government securities

 

$

295,367

 

 

$

-

 

 

$

(3,840

)

 

$

291,527

 

Financial institution debt securities

 

 

327,417

 

 

 

-

 

 

 

(2,154

)

 

 

325,263

 

Corporate debt securities

 

 

67,018

 

 

 

-

 

 

 

(772

)

 

 

66,246

 

Other asset-backed securities

 

 

24,925

 

 

 

-

 

 

 

(428

)

 

 

24,497

 

Total

 

$

714,727

 

 

$

-

 

 

$

(7,194

)

 

$

707,533

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2021

 

 

 

Amortized
Cost

 

 

Gross Unrealized
Gains

 

 

Gross Unrealized
Losses

 

 

Estimated Fair
Value

 

 

 

(In thousands)

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury and other government securities

 

$

301,493

 

 

$

-

 

 

$

(1,016

)

 

$

300,477

 

Financial institution debt securities

 

 

441,068

 

 

 

-

 

 

 

(652

)

 

 

440,416

 

Corporate debt securities

 

 

62,500

 

 

 

-

 

 

 

(151

)

 

 

62,349

 

Other asset-backed securities

 

 

159,707

 

 

 

-

 

 

 

(306

)

 

 

159,401

 

Total

 

$

964,768

 

 

$

-

 

 

$

(2,125

)

 

$

962,643

 

The amortized cost of available-for-sale securities is adjusted for amortization of premiums and accretion of discounts to maturity. At September 30, 2022 and December 31, 2021, the balance in the Company’s accumulated other comprehensive loss was composed of activity related to the Company’s available-for-sale marketable securities and equity method investment. There were no realized gains or losses in the nine months ended September 30, 2022 or for the year ended December 31, 2021. The Company did not reclassify any amounts out of accumulated other comprehensive loss during this period. The Company generally does not intend to sell any investments prior to recovery of their amortized cost basis for any investment in an unrealized loss position. As such, the Company has classified these losses as temporary in nature.

The Company's available-for-sale securities that are classified as short-term marketable securities in the condensed consolidated balance sheet mature within one year or less as of the balance sheet date. Available-for-sale securities that are classified as noncurrent in the condensed consolidated balance sheet are those that mature after one year but within five years from the balance sheet date and that the Company does not intend to dispose of within the next twelve months. At September 30, 2022 and December 31, 2021, the Company did not hold any investments that matured beyond five years of the balance sheet date.